SEC Info - Benchmark Electronics Inc. - ‘10-Q’ for 6/30/20

Page	(sequential)		(alphabetic)	↑Top
		Alternative Formats (Word, et al.) Condensed Consolidated Balance Sheets Condensed Consolidated Statements of Cash Flows Condensed Consolidated Statements of Comprehensive Income (Loss) Condensed Consolidated Statements of Income Condensed Consolidated Statements of Shareholders' Equity Controls and Procedures Exhibits Financial Statements (Unaudited) Item 1 Item 1A Item 2 Item 3 Item 4 Item 6 Legal Proceedings Management's Discussion and Analysis of Financial Condition and Notes to Condensed Consolidated Financial Statements Quantitative and Qualitative Disclosures About Market Risk Results of Operations Risk Factors Signatures Unregistered Sales of Equity Securities and Use of Proceeds
1	1st Page – Filing Submission
"	Item 1
"	Financial Statements (Unaudited)
"	Condensed Consolidated Balance Sheets
"	Condensed Consolidated Statements of Income
"	Condensed Consolidated Statements of Comprehensive Income (Loss)
"	Condensed Consolidated Statements of Shareholders' Equity
"	Condensed Consolidated Statements of Cash Flows
"	Notes to Condensed Consolidated Financial Statements
"	Item 2
"	Management's Discussion and Analysis of Financial Condition and
"	Results of Operations
"	Item 3
"	Quantitative and Qualitative Disclosures About Market Risk
"	Item 4
"	Controls and Procedures
"	Legal Proceedings
"	Item 1A
"	Risk Factors
"	Unregistered Sales of Equity Securities and Use of Proceeds
"	Item 6
"	Exhibits
"	Signatures

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

FORM i 10-Q

_______________

(Mark One)

i ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended i June 30, i 2020 /

i ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________________ to________________

Commission File Number: i 1-10560

i BENCHMARK ELECTRONICS, INC.

(Exact name of registrant as specified in its charter)

i Texas	i 74-2211011
(State or other jurisdiction	(I.R.S. Employer
of incorporation or organization)	Identification No.)
i 56 South Rockford Drive		i 85281
i Tempe, i Arizona		(Zip Code)
(Address of principal executive offices)

( i 623) i 300-7000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
i Common Stock, par value $0.10 per share	i BHE	i New York Stock Exchange, Inc.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. i Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). i Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b–2 of the Exchange Act.


Large accelerated filer ☑	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company i ☐
Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b–2 of the Act). Yes ☐ No ☑

As of August 4, 2020, there were i 36,460,944 shares of common stock of Benchmark Electronics, Inc., par value $0.10 per share, outstanding.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(unaudited)

						June 30,		December 31,
(in thousands, except par value)						2020		2019

Assets
	Current assets:
		Cash and cash equivalents			$	i 351,167	$	i 347,558
		Restricted cash				i 5,252		i 16,398
		Accounts receivable, net of allowance for doubtful accounts of $ i 12,192
			and $ i 10,085, respectively			i 302,068		i 324,424
		Contract assets				i 153,641		i 161,061
		Inventories				i 363,665		i 314,956
		Prepaid expenses and other current assets				i 31,777		i 29,566
		Income taxes receivable				i 549		i 1,119
				Total current assets		i 1,208,119		i 1,195,082
	Property, plant and equipment, net of accumulated depreciation of
				$ i 480,970 and $ i 460,708, respectively		i 198,001		i 205,819
	Operating lease right-of-use assets					i 74,170		i 76,859
	Goodwill					i 192,116		i 192,116
	Deferred income taxes					i 5,336		i 5,274
	Other assets, net					i 80,293		i 84,724
					$	i 1,758,035	$	i 1,759,874

Liabilities and Shareholders’ Equity
	Current liabilities:
		Current installments of long-term debt			$	i 8,912	$	i 8,825
		Accounts payable				i 304,601		i 302,994
		Income taxes payable				i 5,207		i 7,895
		Accrued liabilities				i 145,900		i 139,531
				Total current liabilities		i 464,620		i 459,245
	Long-term debt, less current installments					i 164,664		i 138,912
	Operating lease liabilities					i 64,768		i 67,898
	Other long-term liabilities					i 67,848		i 65,483
	Deferred income taxes					i 11,775		i 13,504
	Shareholders’ equity:
		Preferred stock, $ i 0.10 par value; i 5,000 shares authorized, none issued				i —		i —
		Common stock, $ i 0.10 par value; i 145,000 shares authorized; issued
			and outstanding – i 36,461 and i 36,957, respectively			i 3,646		i 3,696
		Additional paid-in capital				i 508,555		i 512,019
		Retained earnings				i 493,451		i 515,876
		Accumulated other comprehensive loss				( i 21,292)		( i 16,759)
				Total shareholders’ equity		i 984,360		i 1,014,832
		Commitments and contingencies
					$	i 1,758,035	$	i 1,759,874

See accompanying notes to condensed consolidated financial statements.

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income (Loss)

(unaudited)

		Three Months Ended				Six Months Ended
		June 30,				June 30,
(in thousands, except per share data)			2020		2019		2020		2019

Sales		$	i 490,966	$	i 601,602	$	i 1,005,930	$	i 1,204,422
Cost of sales			i 456,294		i 552,379		i 927,897		i 1,105,162
	Gross profit		i 34,672		i 49,223		i 78,033		i 99,260
Selling, general and administrative expenses			i 28,516		i 31,507		i 60,091		i 61,514
Amortization of intangible assets			i 2,371		i 2,361		i 4,752		i 4,728
Restructuring charges and other costs			i 5,657		i 3,414		i 8,572		i 4,990
	Income (loss) from operations		( i 1,872)		i 11,941		i 4,618		i 28,028
Interest expense			( i 2,351)		( i 1,718)		( i 4,053)		( i 3,327)
Interest income			i 287		i 1,053		i 886		i 2,350
Other income (expense)			i 32		i 808		( i 630)		i 2,412
	Income (loss) before income taxes		( i 3,904)		i 12,084		i 821		i 29,463
Income tax expense (benefit)			( i 497)		i 2,637		i 376		i 6,243
	Net income (loss)	$	( i 3,407)	$	i 9,447	$	i 445	$	i 23,220

Earnings (loss) per share:
	Basic	$	( i 0.09)	$	i 0.25	$	i 0.01	$	i 0.59
	Diluted	$	( i 0.09)	$	i 0.24	$	i 0.01	$	i 0.58

Weighted-average number of shares outstanding:
	Basic		i 36,439		i 38,426		i 36,614		i 39,522
	Diluted		i 36,439		i 38,583		i 36,863		i 39,843

See accompanying notes to condensed consolidated financial statements.

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Loss)

(unaudited)

Three Months Ended

Six Months Ended

June 30,

(in thousands)

2020

2019

2020

2019

Net income (loss)

( i 3,407)

i 9,447

i 445

i 23,220

Other comprehensive income (loss):

Foreign currency translation adjustments

i 866

i 585

( i 391)

( i 248)

Unrealized loss on derivative, net of tax

( i 264)

( i 2,261)

( i 4,358)

( i 3,546)

Other

i 101

( i 191)

i 216

( i 206)

Other comprehensive income (loss):

i 703

( i 1,867)

( i 4,533)

( i 4,000)

Comprehensive income (loss)

( i 2,704)

i 7,580

( i 4,088)

i 19,220

See accompanying notes to condensed consolidated financial statements.

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Shareholders’ Equity

(unaudited)

Accumulated

Common Stock

Additional

Other

Total

Par

Paid-in

Retained

Comprehensive

Shareholders’

(in thousands)

Outstanding

Value

Capital

Earnings

Loss

Equity

Balances, December 31, 2019

i 36,957

$ i 3,696

$ i 512,019

$ i 515,876

$ ( i 16,759)

$ i 1,014,832

Stock-based compensation expense

—

i —

i 6,044

i —

i 6,044

Shares repurchased and retired

( i 724)

( i 73)

( i 8,048)

( i 11,208)

i —

( i 19,329)

Stock options exercised

i 17

i 2

i 362

i —

i 364

Vesting of restricted stock units

i 283

i 28

( i 28)

i —

Shares withheld for taxes

( i 72)

( i 7)

( i 1,794)

i —

( i 1,801)

Dividends declared

—

i —

( i 11,662)

i —

( i 11,662)

Net income

—

i —

i 445

i —

i 445

Other comprehensive loss

—

i —

( i 4,533)

Balances, June 30, 2020

i 36,461

$ i 3,646

$ i 508,555

$ i 493,451

$ ( i 21,292)

$ i 984,360

Balances, March 31, 2020

i 36,415

$ i 3,642

$ i 505,283

$ i 502,692

$ ( i 21,995)

$ i 989,622

Stock-based compensation expense

—

i —

i 3,305

i —

i 3,305

Stock options exercised

i 1

i —

i 5

i —

i 5

Vesting of restricted stock units

i 47

i 4

( i 4)

i —

Shares withheld for taxes

( i 2)

i —

( i 34)

i —

( i 34)

Dividends declared

—

i —

( i 5,834)

i —

( i 5,834)

Net loss

—

i —

( i 3,407)

i —

( i 3,407)

Other comprehensive income

—

i —

i 703

Balances, June 30, 2020

i 36,461

$ i 3,646

$ i 508,555

$ i 493,451

$ ( i 21,292)

$ i 984,360

See accompanying notes to condensed consolidated financial statements.

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Shareholders’ Equity

(unaudited)

Accumulated

Common Stock

Additional

Other

Total

Par

Paid-in

Retained

Comprehensive

Shareholders’

(in thousands)

Outstanding

Value

Capital

Earnings

Loss

Equity

Balances, December 31, 2018

i 41,357

$ i 4,136

$ i 554,939

$ i 584,274

$ ( i 11,124)

i 1,132,225

Stock-based compensation expense

—

i —

i 5,720

i —

i 5,720

Shares repurchased and retired

( i 3,908)

( i 391)

( i 43,424)

( i 56,224)

i —

( i 100,039)

Stock options exercised

i 33

i 3

i 690

i —

i 693

Vesting of restricted stock units

i 242

i 24

( i 24)

i —

Shares withheld for taxes

( i 45)

( i 4)

( i 1,238)

i —

( i 1,242)

Dividends declared

—

i —

( i 11,527)

i —

( i 11,527)

Net income

—

i —

i 23,220

i —

i 23,220

Other comprehensive loss

—

i —

( i 4,000)

Balances, June 30, 2019

i 37,679

$ i 3,768

$ i 516,663

$ i 539,743

$ ( i 15,124)

$ i 1,045,050

Balances, March 31, 2019

i 39,169

$ i 3,917

$ i 530,261

$ i 557,804

$ ( i 13,257)

$ i 1,078,725

Stock-based compensation expense

—

i —

i 2,948

i —

i 2,948

Shares repurchased and retired

( i 1,525)

( i 152)

( i 16,951)

( i 21,856)

i —

( i 38,959)

Stock options exercised

i 20

i 2

i 412

i —

i 414

Vesting of restricted stock units

i 15

i 1

( i 1)

i —

Shares withheld for taxes

i —

( i 6)

i —

( i 6)

Dividends declared

—

i —

( i 5,652)

i —

( i 5,652)

Net income

—

i —

i 9,447

i —

i 9,447

Other comprehensive loss

—

i —

( i 1,867)

Balances, June 30, 2019

i 37,679

$ i 3,768

$ i 516,663

$ i 539,743

$ ( i 15,124)

$ i 1,045,050

See accompanying notes to condensed consolidated financial statements.

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(unaudited)

					Six Months Ended
					June 30,
(in thousands)						2020		2019


Cash flows from operating activities:
	Net income				$	i 445	$	i 23,220
	Adjustments to reconcile net income to net cash provided by
		operating activities:
			Depreciation			i 18,813		i 18,420
			Amortization			i 5,718		i 5,705
			Provision for doubtful accounts			i 2,107		( i 1,462)
			Deferred income taxes			( i 330)		i 1,555
			Gain on the sale of property, plant and equipment			( i 139)		( i 25)
			Asset impairments			i 1,214		i 834
			Stock-based compensation expense			i 6,044		i 5,720
	Changes in operating assets and liabilities:
			Accounts receivable			i 20,356		i 106,749
			Contract assets			i 7,420		( i 15,464)
			Inventories			( i 48,668)		( i 6,327)
			Prepaid expenses and other assets			( i 1,234)		i 1,559
			Accounts payable			i 6,980		( i 49,428)
			Accrued liabilities			i 3,091		( i 13,243)
			Operating leases			i 236		i 574
			Income taxes			( i 2,135)		( i 9,615)
				Net cash provided by operations		i 19,918		i 68,772
Cash flows from investing activities:
	Proceeds from sales of investments at par					i —		i 50
	Additions to property, plant and equipment					( i 21,402)		( i 14,163)
	Proceeds from the sale of property, plant and equipment					i 307		i 28
	Additions to purchased software					( i 1,888)		( i 1,332)
	Cash received from business divestitures					i 2,214		i —
	Other					i 55		( i 29)
				Net cash used in investing activities		( i 20,714)		( i 15,446)
Cash flows from financing activities:
	Proceeds from stock options exercised					i 364		i 693
	Employee taxes paid for shares withheld					( i 1,801)		( i 1,242)
	Dividends paid					( i 11,365)		( i 12,079)
	Borrowings under credit agreement					i 110,000		i —
	Principal payments on long-term debt					( i 84,392)		( i 2,441)
	Share repurchases					( i 19,329)		( i 100,039)
				Net cash used in financing activities		( i 6,523)		( i 115,108)
Effect of exchange rate changes						( i 218)		i 293
Net decrease in cash and cash equivalents and restricted cash						( i 7,537)		( i 61,489)
	Cash and cash equivalents and restricted cash at beginning of year					i 363,956		i 458,102
	Cash and cash equivalents and restricted cash at end of period				$	i 356,419	$	i 396,613

See accompanying notes to condensed consolidated financial statements.

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(amounts in thousands, except per share data, unless otherwise noted)

(unaudited)

Note 1 – Basis of Presentation

Benchmark Electronics, Inc. (the Company) is a Texas corporation that provides innovative product design, engineering services, technology solutions and advanced manufacturing services. From initial product concept to volume production, including direct order fulfillment and aftermarket services, the Company has been providing integrated services and solutions to original equipment manufacturers (OEMs) since 1979. The Company serves the following industries: aerospace and defense (A&D), medical technologies, complex industrials, semiconductor capital equipment (Semi-Cap), next-generation telecommunications and advanced computing. The Company has manufacturing operations located in the United States and Mexico (the Americas), Asia and Europe.

The unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the SEC). The financial statements reflect all normal and recurring adjustments necessary in the opinion of management for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (the 2019 10-K).

Management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these financial statements in accordance with generally accepted accounting principles in the United States (U.S. GAAP) with consideration given to the potential impacts of the coronavirus disease 2019 (COVID-19) pandemic. However, actual results could differ materially from these estimates and be significantly affected by the severity and duration of the pandemic, the extent of actions to contain or treat COVID-19, how quickly and to what extent normal economic and operating activity can resume, and the severity and duration of the global economic downturn that results from the pandemic.

For comparative purposes and based on ongoing evaluation of personnel roles involved in the production process, prior year expenses associated with certain personnel have been reclassified from selling, general and administrative expenses to cost of goods sold to conform to the current year presentation.

Note 2 – New Accounting Pronouncements

Adopted in 2020

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This update is effective for annual reporting periods beginning after December 15, 2019. The Company i adopted this update i effective i January 1, 2020 / and the implementation of this update did not have a material impact on its consolidated financial position, results of operations or cash flows.

/ /

Not Yet Adopted

The Company has determined that other recently issued accounting standards will either not have a material impact on its consolidated financial position, results of operations or cash flows, or will not apply to its operations.

Note 3 – Contract Assets

As of June 30, 2020 and December 31, 2019, the Company had $ i 153.6 million and $ i 161.1 million, respectively, in contract assets from contracts with customers. The contract assets primarily relate to the Company’s right to consideration for work completed but not billed at the reporting date. The contract assets are transferred to accounts receivable when the rights become unconditional.

i Significant changes in the contract asset balance during the period are as follows:

	Six Months Ended
	June 30,
(in thousands)		2020		2019
Beginning balance as of December 31,	$	i 161,061	$	i 140,082
Revenue recognized		i 915,600		i 1,109,396
Amounts collected or invoiced		( i 923,020)		( i 1,093,932)
Ending balance as of June 30,	$	i 153,641	$	i 155,546

i i

Note 4 – Inventories
Inventory costs are summarized as follows:
	June 30,		December 31,
(in thousands)		2020		2019

Raw materials	$	i 349,069	$	i 304,069
Work in process		i 9,929		i 8,282
Finished goods		i 4,667		i 2,605
	$	i 363,665	$	i 314,956

/ /

Note 5 – Goodwill and Other Intangible Assets

i Goodwill allocated to the Company’s reportable segments was as follows:

(in thousands)		Americas		Asia		Total
Goodwill as of December 31, 2019 and June 30, 2020	$	154,014	$	38,102	$	192,116

Other assets, net consist primarily of acquired identifiable intangible assets and capitalized purchased software costs. i Intangible assets as of June 30, 2020 and December 31, 2019 were as follows:

		As of June 30, 2020
		Gross				Net
		Carrying	Accumulated			Carrying
(in thousands)		Amount	Amortization			Amount
Customer relationships	$	i 100,124	$	( i 50,154)	$	i 49,970
Purchased software costs		i 43,365		( i 32,637)		i 10,728
Technology licenses		i 28,800		( i 25,669)		i 3,131
Trade names and trademarks		i 7,800		i —		i 7,800
Other		i 868		( i 321)		i 547
Total	$	i 180,957	$	( i 108,781)	$	i 72,176

		As of December 31, 2019
		Gross				Net
		Carrying	Accumulated			Carrying
(in thousands)		Amount	Amortization			Amount
Customer relationships	$	i 100,123	$	( i 46,981)	$	i 53,142
Purchased software costs		i 41,604		( i 32,012)		i 9,592
Technology licenses		i 28,800		( i 24,100)		i 4,700
Trade names and trademarks		i 7,800		i —		i 7,800
Other		i 868		( i 309)		i 559
Total	$	i 179,195	$	( i 103,402)	$	i 75,793

Customer relationships are being amortized on a straight-line basis over a period of i 10 to i 14 years. Capitalized purchased software costs are amortized straight-line over the estimated useful life of the related software, which ranges from i 2 to i 10 years. Technology licenses are being amortized over their estimated useful lives in proportion to the economic benefits consumed. The Company’s acquired trade names and trademarks have been determined to have an indefinite life. i Amortization on the statements of cash flow for the six months ended June 30, 2020 and 2019 was as follows:

	Six Months Ended
	June 30,
(in thousands)		2020		2019
Amortization of intangible assets	$	i 4,752	$	i 4,728
Amortization of capitalized purchased software costs		i 736		i 747
Amortization of debt costs		i 230		i 230
	$	i 5,718	$	i 5,705

i The estimated future amortization expense of acquired intangible assets for each of the next five years is as follows (in thousands):

Year ending December 31,		Amount
2020 (remaining six months)	$	i 5,330
2021		i 8,142
2022		i 8,001
2023		i 6,755
2024		i 5,581

Note 6—Borrowing Facilities

i Long-term debt outstanding as of June 30, 2020 and December 31, 2019 consists of the following:

		June 30,		December 31,
(in thousands)		2020			2019
	Revolving credit facility, due 2023	$	i 30,000	$	i —
	Term loan, due 2023		i 140,625		i 144,375
	Less unamortized debt issuance costs		( i 1,387)		( i 1,616)
	Long-term debt	$	i 169,238	$	i 142,759

On July 20, 2018, the Company entered into a $ i 650 million credit agreement (the Credit Agreement) by and among the Company, certain of its subsidiaries, the lenders party thereto and i Bank of America, N.A., as Administrative Agent, Swingline Lender and a L/C Issuer. The Credit Agreement is comprised of a i 5

-year $ i 500 million revolving credit facility (the Revolving Credit Facility) and a i 5-year $ i 150 million term loan facility (the Term Loan Facility), both with a maturity date of i July 20, 2023. The Term Loan Facility proceeds were used to (i) refinance a portion of existing indebtedness and terminate all commitments under the Company’s prior $ i 430 million credit agreement and (ii) pay the fees, costs and expenses associated with the foregoing and the negotiation, execution and delivery of the Credit Agreement.

The Revolving Credit Facility is available for general corporate purposes. The Credit Agreement includes an accordion feature pursuant to which the Company is permitted to add one or more incremental term loan and/or increase commitments under the Revolving Credit Facility in an aggregate amount not exceeding $ i 275 million, subject to the satisfaction of certain conditions.

The Term Loan Facility is payable in i quarterly principal installments of $ i 1.9 million with the balance payable on i July 20, 2023.

Interest on outstanding borrowings under the Credit Agreement (other than swingline loans) accrues, at the Company’s option, at (a) the London Interbank Offered Rate (LIBOR) plus i 1.0% to i 2.0% or (b) the base rate plus i 0.0% to i 1.0%.

As of June 30, 2020, $ i 140.6 million of the outstanding debt under the Credit Agreement is effectively at a fixed interest rate of i 2.928% (plus the applicable margin) as a result of a $ i 140.6 million notional interest rate swap contract discussed in Note 16. A commitment fee of i 0.20% to i 0.30% per annum (based on the debt to EBITDA ratio) on the unused portion of the revolving credit line is payable quarterly in arrears.

The Credit Agreement is generally secured by a pledge of (a) all the capital stock of the Company’s domestic subsidiaries and i 65% of the capital stock of its directly owned foreign subsidiaries, (b) all or substantially all other personal property of Benchmark and its domestic subsidiaries (including, but not limited to, accounts receivable, contract assets, inventory, intellectual property and fixed assets of Benchmark and its domestic subsidiaries), in each case, subject to customary exceptions and limitations, and (c) all proceeds and products of the property and assets described in (a) and (b) above.

i The Credit Agreement contains certain financial covenants as to interest coverage and debt leverage, and certain customary affirmative and negative covenants, including restrictions on the Company’s ability to incur additional debt and liens, pay dividends, repurchase shares, sell assets and merge or consolidate with other persons. Amounts due under the Credit Agreement could be accelerated upon specified events of default, including a failure to pay amounts due, breach of a covenant, material inaccuracy of a representation, or occurrence of bankruptcy or insolvency, subject, in some cases, to cure periods.

As of June 30, 2020, the Company had $ i 140.6 million in borrowings outstanding under the Term Loan Facility and $ i 30.0 million in borrowings and $ i 3.7 million in letters of credit outstanding under the Revolving Credit Facility, respectively. The Company had $ i 466.3 million available for future borrowings under the Revolving Credit Facility subject to compliance with financial covenants as to interest coverage and debt leverage, in addition to other debt covenant restrictions.

Note 7 – Leases

The Company determines if a contract is or contains a lease at inception. i The Company has entered into leases for certain facilities, vehicles and other equipment. The Company’s leases consist mainly of operating leases which expire at various dates through 2036. i Variable lease payments are generally expensed as incurred and include certain index-based changes in rent, certain nonlease components, such as maintenance and other services provided by the lessor, and other charges included in the lease.

i The components of lease expense were as follows:

			Three Months Ended			Six Months Ended
			June 30,				June 30,
(in thousands)			2020		2019		2020		2019
Finance lease cost:
	Amortization of right-to-use assets (included in depreciation expense)	$	i 177	$	i 178	$	i 355	$	i 356
	Interest on lease liabilities		i 109		i 141		i 227		i 287
Operating lease cost			i 3,997		i 4,232		i 8,138		i 8,680
Short-term lease cost			i 137		i 121		i 378		i 321
Variable lease cost			i 406		i 371		i 916		i 737
	Total lease cost	$	i 4,826	$	i 5,043	$	i 10,014	$	i 10,381


			Six Months Ended
			June 30, 2020			June 30, 2019
Other information:
	Cash paid for amounts included in the measurement of lease liabilities:
	Operating cash flows used for finance lease			$	i 244			$	i 303
	Operating cash flows used for operating leases			$	i 7,897			$	i 7,447
	Financing cash flows used for finance lease			$	i 642			$	i 566
	Right-to-use assets obtained in exchange for new operating lease liabilities			$	i 4,504			$	i 15,206

The lease assets and liabilities were as follows (in thousands):

	June 30,			December 31,
	2020			2019
Finance lease right-of-assets (included in other assets)		$	i 1,956		$	i 2,311
Operating lease right-of-use assets		$	i 74,170		$	i 76,859
Finance lease liability, current (included in current installments of long-term debt)		$	i 1,412		$	i 1,325
Finance lease liability, noncurrent (included in long-term debt)		$	i 2,926		$	i 3,654
Operating lease liabilities, current (included in accrued liabilities)		$	i 11,720		$	i 11,043
Operating lease liabilities, noncurrent		$	i 64,768		$	i 67,898
Weighted average remaining lease term – finance leases		3.0 years			3.5 years
Weighted average remaining lease term – operating leases		9.8 years			10.2 years
Weighted average discount rate – finance leases			10.1%			10.1%
Weighted average discount rate – operating leases			4.7%			4.7%

i Future annual minimum lease payments and finance lease commitments as of June 30, 2020 were as follows (in thousands):

		Operating			Finance
Year ending December 31,			Leases		Leases
	2020 (remaining six months)	$	i 7,658	$	i 895
	2021		i 13,898		i 1,816
	2022		i 10,936		i 1,853
	2023		i 10,109		i 465
	2024		i 8,623		i —
	2025 and thereafter		i 46,026		i —
	Total minimum lease payments	$	i 97,250	$	i 5,029
	Less: imputed interest		( i 20,762)		( i 691)
	Present value of lease liabilities	$	i 76,488	$	i 4,338

As of June 30, 2020, the Company’s future operating leases that have not yet commenced are immaterial.

Note 8 – Common Stock and Stock-Based Awards Plans

Dividends

The Company began declaring and paying quarterly dividends during the first quarter of 2018. For the six months ended June 30, 2020, cash dividends paid totaled $ i 11.4 million. On i June 15, 2020, the Company declared a quarterly cash dividend of $ i 0.16 per share of the Company’s common stock to shareholders of record as of i June 30, 2020. The dividend in the aggregate amount of $ i 5.8 million was paid on i July 14, 2020. The Company’s future dividend policy is subject to the Company’s compliance with applicable law, and depending on, among other things, the Company’s results of operations, financial condition, level of indebtedness, capital requirements, contractual restrictions, restrictions in the Company’s debt agreements, and other factors that the Board of Directors may deem relevant, including the impact of the COVID-19 pandemic. Dividend payments are not mandatory or guaranteed; there can be no assurance that the Company will continue to pay a dividend in the future.

Share Repurchase Authorization

On February 19, 2020, the Board of Directors authorized a $ i 150 million increase to its existing stock repurchase program. On October 26, 2018, the Board of Directors authorized the repurchase of $ i 100 million of the Company’s common stock in addition to the $ i 250 million previously approved on March 6, 2018. As of June 30, 2020, the Company had an aggregate $ i 210.1 million remaining under its stock repurchase program.

Stock-Based Compensation

The Company’s 2019 Omnibus Incentive Compensation Plan (the 2019 Plan) authorizes the Company, upon approval of the Compensation Committee of the Board of Directors, to grant a variety of awards, including stock options, restricted shares and restricted stock units (both time-based and performance-based) and other forms of equity awards, or any combination thereof, to any director, officer, employee or consultant (including any prospective director, officer, employee or consultant) of the Company. Stock options (which have not been awarded since 2015) are granted to employees with an exercise price equal to the market price of the Company’s common stock on the date of grant, generally vest over a four-year period from the date of grant and have a term of i 10 years. Time-based restricted stock units granted to employees generally vest over a four-year period from the date of grant, subject to the continued employment of the employee by the Company. Performance-based restricted stock units generally vest over a three-year performance cycle, which includes the year of the grant, and are based upon the Company’s achievement of specified performance metrics. Awards under the 2019 Plan to non-employee directors

have been in the form of restricted stock units, which vest in equal annual installments over a one-year period, starting on the grant date.

As of June 30, 2020, i 2.7 million additional common shares were available for issuance under the Company’s 2019 Plan.

All share-based payments to employees, including grants of employee stock options, are recognized in the financial statements based on their grant date fair values. The total compensation cost recognized for stock-based awards was $ i 3.3 million and $ i 6.0 million for the three and six months ended June 30, 2020, respectively, and $ i 2.9 million and $ i 5.7 million for the three and six months ended June 30, 2019, respectively. The total income tax benefit recognized in the Condensed Consolidated Statements of Income (Loss) for stock-based awards was $ i 0.8 million and $ i 1.4 million for the three and six months ended June 30, 2020, respectively, and $ i 0.7 million and $ i 1.4 million for the three and six months ended June 30, 2019, respectively. Awards of restricted stock units and performance-based restricted stock units are valued at the closing market price of the Company’s common stock on the date of grant. For performance-based restricted stock units, compensation expense is based on the probability that the performance goals will be achieved, which is monitored by management throughout the requisite service period. When it becomes probable, based on the Company’s expectation of performance during the measurement period, that more or less than the previous estimate of the awarded shares will vest, an adjustment to stock-based compensation expense is recognized as a change in accounting estimate.

i As of June 30, 2020, the unrecognized compensation cost and remaining weighted-average amortization period related to stock-based awards were as follows:

		Performance-
	Time-based	based
	Restricted	Restricted
	Stock	Stock
(in thousands, except remaining period data)	Units	Units⁽¹⁾
Unrecognized compensation cost	$ i 25,414	$ i 6,296
Remaining weighted-average
amortization period	2.7 years	2 years

⁽¹⁾ Based on the probable achievement of the performance goals identified in each award.

The total cash received by the Company as a result of stock option exercises for the six months ended June 30, 2020 and 2019 was approximately $ i 0.4 million and $ i 0.7 million, respectively. The actual tax benefit realized as a result of stock option exercises and the vesting of other share-based awards during the six months ended June 30, 2020 and 2019 was $ i 1.7 million and $ i 1.6 million, respectively. For the six months ended June 30, 2020 and 2019, the total intrinsic value of stock options exercised was $ i 0.1 million and $ i 0.2 million, respectively.

The Company awarded performance-based restricted stock units to employees during the six months ended June 30, 2020 and 2019. The number of performance-based restricted stock units that will ultimately be earned will not be determined until the end of the corresponding performance periods, and may vary from as low as zero to as high as 2.5 times the target number depending on the level of achievement of certain performance goals. The level of achievement of these goals is based upon the financial results of the Company for the last full calendar year within the performance period. The performance goals consist of certain levels of achievement using the following financial metrics: revenue, operating income margin, and return on invested capital. If the performance goals are not met based on the Company’s financial results, the applicable performance-based restricted stock units will not vest and will be forfeited. Shares subject to forfeited performance-based restricted stock units will be available for issuance under the Company’s 2019 Plan.

i The following table summarizes activities relating to the Company’s stock options:

			Weighted-
		Weighted-	Average	Aggregate
	Number of	Average	Remaining	Intrinsic
	Options	Exercise	Contractual	Value
	(in thousands)	Price	Term (Years)	(in thousands)
Outstanding as of December 31, 2019	i 270	$ i 20.02
Exercised	( i 20)	i 22.74
Outstanding and exercisable as of June 30, 2020	i 250	$ i 19.80	i 2.91	$ i 621

The aggregate intrinsic value in the table above is before income taxes and is calculated as the difference between the exercise price of the underlying options and the Company’s closing stock price as of the last business day of the period ended June 30, 2020 for options that had exercise prices that were below the closing price.

i The following table summarizes the activities related to the Company’s time-based restricted stock units:

		Weighted-
	Number of	Average
	Units	Grant Date
	(in thousands)	Fair Value
Non-vested awards outstanding as of December 31, 2019	i 893	$ i 28.06
Granted	i 525	i 26.61
Vested	( i 283)	i 27.56
Forfeited	( i 41)	i 28.56
Non-vested awards outstanding as of June 30, 2020	i 1,094	$ i 27.47

i The following table summarizes the activities related to the Company’s performance-based restricted stock units:

		Weighted-
	Number of	Average
	Units	Grant Date
	(in thousands)	Fair Value
Non-vested awards outstanding as of December 31, 2019	i 384	$ i 28.89
Granted ⁽¹⁾	i 165	i 28.02
Forfeited	( i 181)	i 30.04
Non-vested awards outstanding as of June 30, 2020	i 368	$ i 27.93

⁽¹⁾Represents target number of units that can vest based on the achievement of the performance goals.

i i /

Note 9 – Income Taxes
Income tax expense (benefit) consists of the following:
	Six Months Ended
	June 30,
(in thousands)		2020		2019
Federal – current	$	i 237	$	i 62
Foreign – current		i 426		i 3,747
State – current		i 43		i 879
Deferred		( i 330)		i 1,555
	$	i 376	$	i 6,243

Income tax expense differs from the amount computed by applying the U.S. federal statutory income tax rate to income before income taxes primarily due to the mix of taxable income by taxing jurisdiction, the impact of tax incentives and tax holidays in foreign locations, state income taxes (net of federal benefit) and the U.S. tax under the global intangible low-taxed income (GILTI) provisions. GILTI requires the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiaries tangible fixed assets. The taxable earnings can be offset by a limited deemed paid foreign tax credit with no carrybacks or carryforwards available. The Company accounts for the GILTI as a period cost and does not include it as a factor in the determination of deferred taxes.

As of December 31, 2019, the Company had approximately $ i 313.9 million in cumulative undistributed foreign earnings of its foreign subsidiaries. These earnings would not be subject to U.S. income tax, if distributed to the Company. During 2018, the Company changed its assertion on its foreign subsidiaries earnings that are permanently reinvested. A certain amount of earnings from specific foreign subsidiaries are permanently reinvested, and certain foreign earnings from other specific foreign subsidiaries are considered to be non-permanently reinvested and are available for immediate distribution to the Company. Income taxes have been accrued on the non-permanently reinvested foreign earnings including any applicable local withholding taxes.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in the United States in response to the COVID-19 pandemic. The CARES Act among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021, and contains modifications on the limitation of business interest for tax years beginning in 2019 and 2020. The Company has evaluated the impact of these provisions and has determined these provisions did not have any impact on the six months ended June 30, 2020. In addition, the CARES Act allows for employee retention tax credits to be taken in U.S. payroll tax filings and allows for the deferral of the employer portion of social security taxes with 50% to be paid at the end of calendar years 2021 and 2022, respectively. Accordingly, the Company has deferred the payment of the employer portion of social security taxes for the three months ended June 30, 2020 until the end of 2021 and 2022, respectively. The Company has also determined it is entitled to employee retention credits and has filed for the credits in the second quarter payroll tax reports pursuant to the guidance provided by the Internal Revenue Service. The amount of credits has been recorded in operating expenses for the three months ended June 30, 2020.

The Company has been granted certain tax incentives, including tax holidays, for its subsidiaries in Malaysia and Thailand that will expire at various dates, unless extended or otherwise renegotiated, through i 2021 in Malaysia and i 2028 in Thailand, and are subject to certain conditions with which the Company expects to comply.

i The net impact of these tax incentives was to lower foreign income tax expense for the six months ended June 30, 2020 and 2019 by approximately $ i 2.3 million (approximately $ i 0.06 per dilutedshare) and $ i 3.0 million (approximately $ i 0.08 per diluted share), respectively, as follows: /

	Six Months Ended
	June 30,
(in thousands)		2020		2019
Malaysia		i 1,293		i 1,486
Thailand		i 966		i 1,542
	$	i 2,259	$	i 3,028

As of June 30, 2020, the total amount of the reserve for uncertain tax benefits including interest and penalties was $ i 0.6 million. The reserve is classified as a current or long-term liability in the Condensed Consolidated Balance Sheets based on the Company’s expectation of when the items will be settled. The Company records interest expense and penalties accrued in relation to uncertain income tax benefits as a component of current income tax expense.

The Company and its subsidiaries in Brazil, China, Ireland, Malaysia, Mexico, the Netherlands, Romania, Singapore, Thailand and the United States remain open to examination by the various local taxing authorities, in total or in part, for fiscal years 2012 to 2019. Currently, the Company does not have any ongoing income tax examinations by any jurisdiction. During such income tax examinations, disputes may occur as to matters of fact or law. Also, in most tax jurisdictions, the passage of time without examination will result in the expiration of applicable statutes of limitations thereby precluding examination of the tax period(s) for which such statute of limitation has expired. The Company believes that it has adequately provided for its tax liabilities.

Note 10 – Revenue

The Company’s revenues are generated primarily from the sale of manufactured products built to customer specifications. The Company also generates revenue from design, development and engineering services, in addition to the sale of other inventory.

Revenue is measured based on consideration specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a manufactured product to a customer. The Company’s contracts with customers are generally short-term in nature. Customers are generally billed when the product is shipped or as services are performed. Under the majority of the Company’s manufacturing contracts with customers, the customer controls all the work-in-progress as products are being built. Revenues under these contracts are recognized progressively based on the cost-to-cost method. For other manufacturing contracts, the customer does not take control of the product until it is completed. Under these contracts, the Company recognizes revenue upon transfer of control of product to the customer. Revenue from design, development and engineering services is recognized over time as the services are performed. The Company assumes no significant obligations after shipment as it typically warrants workmanship only. Therefore, the warranty provisions are generally not significant.

If the Company records revenue, but does not issue an invoice, a contract asset is recognized. The contract asset is transferred to accounts receivable when the entitlement to payment becomes unconditional.

Taxes assessed by governmental authorities that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue.

Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs and are included in cost of sales.

Disaggregation of revenue

In the following tables, revenue is disaggregated by market sector. The tables also include a reconciliation of the disaggregated revenue with the reportable operating segments.

			Reportable Operating Segments
			Three Months Ended June 30, 2020
(in thousands)			Americas		Asia		Europe		Total
Market Sector:
	Industrials	$	i 24,298		i 49,379		i 13,453	$	i 87,130
	A&D		i 80,939		i —		i 7,585		i 88,524
	Medical		i 72,434		i 55,890		i 6,427		i 134,751
	Semi-Cap		i 37,321		i 37,151		i 12,379		i 86,851
	Computing		i 35,487		i 8,366		i —		i 43,853
	Telecommunication		i 21,020		i 28,789		i 48		i 49,857
	External revenue		i 271,499		i 179,575		i 39,892		i 490,966
	Elimination of intersegment sales		i 17,301		i 8,804		i 332		i 26,437
	Segment revenue	$	i 288,800	$	i 188,379	$	i 40,224	$	i 517,403

			Six Months Ended June 30, 2020
			Americas		Asia		Europe		Total
Market Sector:
	Industrials	$	i 58,243	$	i 97,604	$	i 34,109	$	i 189,956
	A&D		i 193,951		i —		i 13,773		i 207,724
	Medical		i 141,813		i 100,093		i 10,821		i 252,727
	Semi-Cap		i 67,770		i 74,443		i 27,358		i 169,571
	Computing		i 65,561		i 14,893		i —		i 80,454
	Telecommunication		i 47,669		i 57,448		i 381		i 105,498
	External revenue		i 575,007		i 344,481		i 86,442		i 1,005,930
	Elimination of intersegment sales		i 28,189		i 15,507		i 782		i 44,478
	Segment revenue	$	i 603,196	$	i 359,988	$	i 87,224	$	i 1,050,408

			Reportable Operating Segments
			Three Months Ended June 30, 2019
(in thousands)			Americas		Asia		Europe		Total
Market Sector:
	Industrials	$	i 43,618	$	i 51,645	$	i 19,401	$	i 114,664
	A&D		i 98,523		i —		i 8,442		i 106,965
	Medical		i 67,962		i 41,446		i 4,779		i 114,187
	Semi-Cap		i 26,139		i 23,726		i 12,585		i 62,450
	Computing		i 119,907		i 12,731		i 52		i 132,690
	Telecommunication		i 34,855		i 35,375		i 416		i 70,646
	External revenue		i 391,004		i 164,923		i 45,675		i 601,602
	Elimination of intersegment sales		i 13,158		i 9,247		i 223		i 22,628
	Segment revenue	$	i 404,162	$	i 174,170	$	i 45,898	$	i 624,230



			Six Months Ended June 30, 2019
			Americas		Asia		Europe		Total
Market Sector:
	Industrials	$	i 86,386	$	i 107,227	$	i 37,424	$	i 231,037
	A&D		i 194,860		i —		i 15,994		i 210,854
	Medical		i 126,374		i 81,904		i 9,387		i 217,665
	Semi-Cap		i 54,538		i 48,469		i 25,464		i 128,471
	Computing		i 230,174		i 26,741		i 85		i 257,000
	Telecommunication		i 77,629		i 80,631		i 1,135		i 159,395
	External revenue		i 769,961		i 344,972		i 89,489		i 1,204,422
	Elimination of intersegment sales		i 26,259		i 16,607		i 369		i 43,235
	Segment revenue	$	i 796,220	$	i 361,579	$	i 89,858	$	i 1,247,657

For the six months ended June 30, 2020 and 2019, i 91% and i 92%, respectively, of the Company’s revenue was recognized as products and services transferred over time.

Note 11 – Accounts Receivable Sale Program

As of June 30, 2020, in connection with three trade accounts receivable sale programs with unaffiliated financial institutions, the Company may elect to sell, at a discount, on an ongoing basis, up to a maximum of $ i 120.0 million of specific accounts receivable at any one time.

During the three months ended June 30, 2020 and 2019, the Company sold $ i 77.9 million and $ i 77.7 million, respectively, of accounts receivable under this program, and in exchange, the Company received cash proceeds of $ i 77.7 million and $ i 77.4 million, respectively, net of the discount. During the six months ended June 30, 2020 and 2019, the Company sold $ i 154.3 million and $ i 130.6 million, respectively, of accounts receivable under this program, and in exchange, the Company received cash proceeds of $ i 154.0 million and $ i 130.2 million, respectively, net of the discount. The loss on the sale resulting from the discount was recorded to other income (expense), net within the Condensed Consolidated Statements of Income.

Note 12 – Contingencies

The Company is involved in various legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operations.

Note 13 – Restructuring Charges

The Company has undertaken initiatives to restructure its business operations to improve utilization and realize cost savings. These initiatives have included changing the number and location of production facilities, largely to align capacity and infrastructure with current and anticipated customer demand. This alignment includes transferring programs from higher cost geographies to lower cost geographies. The process of restructuring entails moving production between facilities, reducing staff levels, realigning our business processes, reorganizing our management and other activities.

The Company recognized restructuring charges during 2020 and 2019 primarily related to facility transitions in the Americas, capacity reduction and reductions in workforce in certain facilities across various regions. i The following table summarizes the 2020 activity in the accrued restructuring balances related to the restructuring activities initiated prior to June 30, 2020:

Balance as of

Foreign

Balance as of

December 31,

Restructuring

Cash

Non-Cash

Exchange

June 30,

(in thousands)

2019

Charges

Payment

Activity

Adjustments

2020

2020 Restructuring:

Severance

i —

i 4,486

( i 1,317)

i —

i 3,169

Leased facilities and equipment

i —

i 148

i —

( i 145)

i —

i 3

Other exit costs

i —

i 73

( i 40)

i —

i 33

i —

i 4,707

( i 1,357)

( i 145)

i —

i 3,205

2019 Restructuring:

Severance

i 3,956

( i 1,183)

( i 2,013)

( i 72)

i —

i 688

Leased facilities and equipment

i —

i 2,550

( i 843)

( i 1,144)

i —

i 563

Other exit costs

i —

i 1,238

( i 251)

( i 729)

i —

i 258

i 3,956

i 2,605

( i 3,107)

( i 1,945)

i —

i 1,509

Total

i 3,956

i 7,312

( i 4,464)

( i 2,090)

i —

i 4,714

In addition, during the six months ended June 30, 2020, we incurred $ i 1.0 million in costs related to an asset impairment in Asia.

Note 14 —Ransomware Incident

During the fourth quarter ended December 31, 2019, some of the Company’s systems were affected by a ransomware incident that encrypted information on its systems and disrupted customer and employee access to its applications and services. The Company immediately took steps to isolate the impact and implemented measures to prevent additional systems from being affected, including taking its network offline as a precaution. In connection with this incident, third party consultants and forensic experts were engaged to assist with the restoration and remediation of the Company’s systems and, with the assistance of law enforcement, to investigate the incident. The Company has found no evidence that customer or employee data was exfiltrated from its network.

The Company restored connectivity and resumed operations quickly following the ransomware incident. However, fourth quarter 2019 operations were adversely affected by the inefficiencies caused by taking the network offline for a period of time. As a result, the Company’s fourth quarter 2019 revenue was also adversely affected as the Company was unable to fulfill a portion of customer demand during the quarter.

We do have insurance coverage, including cyber insurance, and are working diligently with our insurance carriers on claims to recover costs incurred. We expect that the insurance recovery process will be ongoing throughout 2020.

In 2019, ransomware incident related costs incurred totaled $ i 7.7 million, net of estimated insurance recoveries of $ i 5.0 million. These costs were primarily comprised of certain employee related expenses and various third party consulting services including forensic experts, legal counsel and other IT professional expenses. Further insurance recoveries will be recorded when considered probable. During the six months ended June 30, 2020, the Company collected $ i 3.0 million of its recorded insurance receivable.

Note 15 – Earnings Per Share

Basic earnings per share is computed using the weighted-average number of shares outstanding. Diluted earnings per share is computed using the weighted-average number of shares outstanding adjusted for the incremental shares attributed to outstanding stock equivalents. Stock equivalents include common stock issuable upon the exercise of stock options and other equity instruments and are computed using the treasury stock method. Under the treasury stock method, the exercise price of a share and the amount of compensation cost, if any, for future service that the Company has not yet recognized are assumed to be used to repurchase shares in the current period. In periods when losses are reported, the weighted-average number of shares outstanding excludes stock equivalents because their inclusion would have an anti-dilutive effect.

i The following table sets forth the calculation of basic and diluted earnings per share:

Three Months Ended

Six Months Ended

June 30,

(in thousands, except per share data)

2020

2019

2020

2019

Net income (loss)

( i 3,407)

i 9,447

i 445

i 23,220

Denominator for basic earnings per share -

weighted-average number of common

shares outstanding during the period

i 36,439

i 38,426

i 36,614

i 39,522

Incremental common shares attributable to

exercise of dilutive options

i —

i 74

i 49

i 75

Incremental common shares attributable

to outstanding restricted stock units

i —

i 83

i 200

i 246

Denominator for diluted earnings per share

i 36,439

i 38,583

i 36,863

i 39,843

Basic earnings (loss) per share

( i 0.09)

i 0.25

i 0.01

i 0.59

Diluted earnings (loss) per share

( i 0.09)

i 0.24

i 0.01

i 0.58

Potentially dilutive securities totaling i 0.3 million shares for the three months ended June 30, 2020 were not included in the computation of diluted loss per share because their effect would have decreased the loss per share. Restricted stock units totaling i 0.5 million shares for the six months ended June 30, 2020 were not included in the computation of diluted earnings per share because their effect would have been anti-dilutive. Restricted stock units totaling i 0.4 million and i 0.1 million shares, respectively, for the three and six months ended June 30, 2019 were not included in the computation of diluted earnings per share because their effect would have been anti-dilutive.

Note 16 – Financial Instruments

The Company’s financial instruments include cash equivalents, accounts receivable, other receivables, accounts payable, accrued liabilities and long-term debt. The Company believes that the carrying values of these instruments approximate fair value. The Company uses derivative instruments to manage the variability of foreign currency obligations and interest rates. The Company does not enter into derivatives for speculative purposes. As of June 30, 2020, all the Company’s derivative instruments were recorded at fair value using Level 3 inputs.

The forward currency exchange contract in place as of June 30, 2020 has not been designated as an accounting hedge and, therefore, changes in fair value are recorded within the Condensed Consolidated Statements of Income.

The Company has an interest rate swap agreement, with a notional amount of $ i 140.6 million and $ i 144.4 million as of June 30, 2020 and December 31, 2019, respectively, to hedge a portion of its interest rate exposure on outstanding borrowings under the Credit Agreement. Under this interest rate swap agreement, the Company receives variable rate interest payments based on the one-month LIBOR rate and pays fixed rate interest payments. The fixed interest rate for the contract is i i 2.928 / %. The effect of this swap is to convert a portion of the floating rate interest expense to fixed interest rate expense. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the Credit Agreement, the interest rate contract was determined to be highly effective, and thus qualifies and has been designated as a cash flow hedge. As such, changes in the fair value of the interest rate swap are recorded in other comprehensive income (loss) on the accompanying Condensed Consolidated Balance Sheets until earnings are affected by the variability of cash flows.

The fair value of the interest rate swap was an $ i 11.2 million liability as of June 30, 2020 and a $ i 6.3 million liability as of December 31, 2019 recorded in other long-term liabilities. During the six months ended June 30, 2020, the Company recorded an unrealized loss of $ i 4.9 million ($ i 3.7 million net of tax) on the swap in other comprehensive income (loss).

As of December 31, 2017, the Company had an interest rate swap agreement with a notional amount of $ i 155.3 million with a fixed interest rate of i 1.4935% which was terminated in October 2018 for $ i 3.5 million. This gain is being amortized to offset interest expense over the original term of the swap agreement. During the six months ended June 30, 2020, the Company transferred unrealized gains of $ i 0.9 million ($ i 0.7 million net of tax) on the terminated swap to interest expense. See Note 17.

i Note 17 – Accumulated Other Comprehensive Loss i The changes in accumulated other comprehensive loss by component were as follows: /

Foreign

currency

Derivative

translation

instruments,

(in thousands)

adjustments

net of tax

Other

Total

Balances, December 31, 2019

( i 12,425)

( i 3,600)

( i 734)

( i 16,759)

Other comprehensive income (loss)

before reclassifications

( i 391)

( i 3,686)

i 216

( i 3,861)

Amounts reclassified from accumulated

other comprehensive income (loss)

i —

( i 672)

i —

( i 672)

Net current period other comprehensive income (loss)

( i 391)

( i 4,358)

i 216

( i 4,533)

Balances, June 30, 2020

( i 12,816)

( i 7,958)

( i 518)

( i 21,292)

See Note 16 for further explanation of the change in derivative instruments that is recorded in Accumulated Other Comprehensive Loss. Amounts reclassified from accumulated other comprehensive loss during 2020 primarily affected interest expense.

Note 18 – Segment and Geographic Information

The Company currently has manufacturing facilities in the Americas, Asia and Europe to serve its customers. The Company is operated and managed geographically, and management evaluates performance and allocates the Company’s resources on a geographic basis. Intersegment sales are generally recorded at prices that approximate arm’s length transactions. Operating segments’ measure of profitability is based on income from operations, which includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. The operating margin of each segment reflects the cost structure of the segments and are not comparable. The accounting policies for the reportable operating segments are the same as for the Company taken as a whole. The Company has three reportable operating segments: Americas, Asia and Europe. i Information about operating segments is as follows:

		Three Months Ended				Six Months Ended
		June 30,				June 30,
(in thousands)			2020		2019			2020		2019

Net sales:
	Americas	$	i 288,800	$	i 404,162		$	i 603,196	$	i 796,220
	Asia		i 188,379		i 174,170			i 359,988		i 361,579
	Europe		i 40,224		i 45,898			i 87,224		i 89,858
	Elimination of intersegment sales		( i 26,437)		( i 22,628)			( i 44,478)		( i 43,235)
		$	i 490,966	$	i 601,602		$	i 1,005,930	$	i 1,204,422

Depreciation and amortization:
	Americas	$	i 5,762	$	i 5,296		$	i 11,347	$	i 10,677
	Asia		i 2,732		i 2,732			i 5,446		i 5,543
	Europe		i 700		i 758			i 1,425		i 1,572
	Corporate		i 3,145		i 3,167			i 6,313		i 6,333
		$	i 12,339	$	i 11,953		$	i 24,531	$	i 24,125

Income from operations:
	Americas	$	( i 787)	$	i 17,332		$	i 11,638	$	i 37,560
	Asia		i 17,024		i 13,072			i 28,022		i 28,457
	Europe		i 686		i 2,284			i 2,875		i 3,224
	Corporate and intersegment eliminations		( i 18,795)		( i 20,747)			( i 37,917)		( i 41,213)
			( i 1,872)		i 11,941			i 4,618		i 28,028
	Interest expense		( i 2,351)		( i 1,718)			( i 4,053)		( i 3,327)
	Interest income		i 287		i 1,053			i 886		i 2,350
	Other income (expense)		i 32		i 808			( i 630)		i 2,412
	Income before income taxes	$	( i 3,904)	$	i 12,084		$	i 821	$	i 29,463

Capital expenditures:
	Americas	$	i 6,598	$	i 2,947		$	i 15,858	$	i 7,700
	Asia		i 791		i 1,098			i 3,316		i 3,936
	Europe		i 196		i 343			i 1,042		i 731
	Corporate		i 2,809		i 1,033			i 3,074		i 3,128
		$	i 10,394	$	i 5,421		$	i 23,290	$	i 15,495

			June 30,	December 31,
(in thousands)			2020		2019

Total assets:
	Americas	$	i 792,837	$	i 792,180
	Asia		i 535,741		i 533,508
	Europe		i 127,069		i 139,977
	Corporate and other		i 302,388		i 294,209
		$	i 1,758,035	$	i 1,759,874

i Geographic net sales information reflects the destination of the product shipped. Long-lived assets information is based upon the physical location of the asset.

		Three Months Ended				Six Months Ended
		June 30,				June 30,
(in thousands)			2020		2019		2020		2019

Geographic net sales:
	United States	$	i 318,509	$	i 416,465	$	i 654,876	$	i 834,829
	Singapore		i 55,917		i 41,687		i 110,538		i 84,404
	Asia		i 40,207		i 50,058		i 78,526		i 93,965
	Europe		i 55,756		i 65,048		i 122,279		i 138,393
	Other Foreign		i 20,577		i 28,344		i 39,711		i 52,831
		$	i 490,966	$	i 601,602	$	i 1,005,930	$	i 1,204,422

						June 30,		December 31,
							2020		2019
Long-lived assets:
	United States					$	i 238,139	$	i 247,074
	Asia						i 71,472		i 76,507
	Europe						i 19,027		i 20,258
	Other						i 23,826		i 23,563
						$	i 352,464	$	i 367,402

i i

Note 19 – Supplemental Cash Flow and Non-Cash Information

The following information concerns supplemental disclosures of cash payments.

Three Months Ended

Six Months Ended

June 30,

(in thousands)

2020

2019

2020

2019

Income taxes paid, net

i 932

i 12,042

i 2,967

i 14,284

Interest paid

i 2,488

i 2,032

i 4,427

i 4,022

Non-cash investing activity:

Additions to property, plant and equipment

in accounts payable

i 3,677

i 5,660

/ /

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This quarterly report (this Report) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act). These forward-looking statements are identified as any statement that does not relate strictly to historical or current facts and may include words such as “anticipate,” “believe,” “intend,” “plan,” “projection,” “forecast,” “strategy,” “position,” “continue,” “estimate,” “expect,” “may,” “will,” or the negative or other variations thereof. In particular, statements, express or implied, concerning future operating results, including guidance for third quarter 2020 results and beyond, our ability to generate sales, income or cash flow, the anticipated impact of the COVID-19 pandemic, our anticipated plans and responses to the COVID-19 pandemic, our expected revenue mix, our business strategy and strategic initiatives, our repurchases of shares of our common stock and our intentions concerning the payment of dividends, among others, are forward-looking statements. Although we believe these statements are based upon reasonable assumptions, they involve risks, uncertainties and assumptions that are beyond our ability to control or predict, relating to operations, markets and the business environment generally, including those discussed in Part I, Item 1A of the 2019 10-K, in Part II, Item 1A of this Report and in any of our subsequent reports filed with the SEC. In particular, these statements also depend on the duration, severity and evolution of the COVID-19 pandemic and related risks, including government and other third-party responses to it and the consequences for the global economy, our business and the businesses of our suppliers and customers, as well as our ability (or inability) to execute on its plans to respond to the COVID-19 pandemic. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes, including the future results of our operations, may vary materially from those indicated. Undue reliance should not be placed on any forward-looking statements. Forward-looking statements are not guarantees of performance. The following discussion should be read in conjunction with the Condensed Consolidated Financial Statements and accompanying notes, and the 2019 10-K. All forward-looking statements included in this document are based upon information available to the company as of the date of this document, and it assumes no obligation to update them.

OVERVIEW

We are a worldwide provider of innovative product design, engineering services, technology solutions and advanced manufacturing services (both electronic manufacturing services (EMS) and precision technology machining services). In this Report, references to Benchmark, the Company or use of the words “we”, “our” and “us” include Benchmark’s subsidiaries unless otherwise noted.

From initial product concept to volume production, including direct order fulfillment and aftermarket services, Benchmark has been providing integrated services and solutions to original equipment manufacturers (OEMs) since 1979. Today, Benchmark proudly serves the following industries: aerospace and defense (A&D), medical technologies, complex industrials, semiconductor capital equipment (Semi-Cap), next-generation telecommunications and advanced computing.

Our customer engagement focuses on three principal areas:

•Engineering Services, which includes turnkey product design, design for manufacturability, manufacturing process and test development, concurrent and sustaining engineering and regulatory services. Our engineering services may be for systems, sub-systems, printed circuit boards and assemblies, and components. We provide these services across all the industries we serve, but focus primarily in regulated industries such as medical, complex industrials, aerospace and defense, and next-generation telecommunications.

•Technology Solutions, which involve developing a library of building blocks or reference designs primarily in defense solutions, surveillance systems, radio frequency and high-speed design, and front-end managed connectivity data collection systems. We often merge these technology solutions with engineering services in order to support manufacturing services. Our reference designs can be utilized across a variety of industries, but we have significant capabilities in the aerospace and defense and next-generation telecommunications markets. We have also developed stronger capabilities in radio frequency (RF) and high-speed design for both components and substrates. The need to reduce Size, Weight, and Power (SWaP) to accommodate embedding high frequency electronic communications into specific designs is important to customers in the aerospace and defense, medical, and next-generation telecommunications markets.

•Manufacturing Services, which include producing printed circuit board assemblies (PCBAs) using both traditional surface mount technologies (SMT) and microelectronics are then often integrated into a subsystem assembly, or a box build as part of systems integration. Systems integration often involves building a finished assembly that includes PCBAs, complex subsystem assemblies, mechatronics, displays, optics, and other components. These final products may be configured to order and delivered directly to the end-customer across all the industries we serve. Manufacturing services also includes precision technology manufacturing comprised of precision machining, advanced metal joining, assembly and functional testing primarily for customers in the semiconductor capital equipment as well as the medical and aerospace and defense markets.

Our core strength lies in our ability to provide concept-to-production solutions in support of our customers. Our global manufacturing presence increases our ability to respond to our customers’ needs by providing accelerated time-to-market and time-to-volume production of high-quality products – especially for complex products with lower volume and higher mix in regulated markets. These capabilities enable us to build strong strategic relationships with our customers and to become an integral part of their business.

We believe our primary competitive advantages are our engineering services (including product design), technology solutions, and manufacturing services (including electronics and precision technology capabilities) provided by highly skilled personnel. We continue to invest in our business to expand our skills and service offerings from direct customer inputs. We have a closed-loop feedback system in place to respond to customer ideas to enhance our future designs and manufacturing solutions in support of the full life cycle of their products. These solutions offload the electronics design work from our customers so they can focus on product areas where they can provide more value add and, in the process, accelerate their time-to-market and reduce their product development costs. Working closely with our customers and responding promptly to their needs, we become an integral part of their development process helping them bring products to market faster and more economically.

In addition, we believe that a strong focus on human capital through the talent we hire and retain is critical to maintaining our competitiveness. We are driving a customer-centric organization with a high degree of accountability and ownership to develop processes necessary to exceed customer expectations and deliver financial performance aligned to our goals. Through our employee feedback process, we solicit and act upon information to improve our company and better support our customers and business processes in the future. We have taken steps to attract the best leaders into our business and we are accelerating our efforts to mentor and develop key leaders for the future.

Our customers often face challenges in designing supply chains, demand planning, procuring materials and managing their inventories efficiently due to fluctuations in their customer demand, product design changes, short product life cycles and component price fluctuations.

We employ enterprise resource planning (ERP) systems and lean manufacturing principles to manage procurement and manufacturing processes in an efficient and cost-effective manner so that, where possible, components arrive on a just-in-time, as-and-when-needed basis. Because we are a significant purchaser of electronic components and other raw materials, we are able to capitalize on the economies of scale associated with our relationships with suppliers to negotiate price discounts, obtain components and other raw materials that are in short supply, and return excess components. Our agility and expertise in supply chain management and our relationships with suppliers across the supply chain enable us to help reduce our customers’ cost of goods sold and inventory exposure.

We recognize revenue as the customer takes control of the manufactured products built to customer specifications. We also generate revenue from our design, development and engineering services, in addition to the sale of other inventory.

Revenue is measured based on the consideration specified in a contract with a customer. Under the majority of our manufacturing contracts with customers, the customer controls all the work-in-progress as products are being built. Revenues under these contracts are recognized over time based on the cost-to-cost method. Under other manufacturing contracts, the customer does not take control of the product until it is completed. Under these contracts, we recognize revenue upon transfer of control of product to the customer, which is generally when the goods are shipped. Revenue from engineering services that include design and development elements also continues to be recognized over time as the services are performed. We assume no significant obligations after shipment as we typically warrant workmanship only. Therefore, the warranty provisions are generally not significant.

COVID-19 Pandemic Update

In late 2019, there was an outbreak of a new strain of coronavirus (COVID-19) first identified in Wuhan, Hubei Province, China, which has since spread globally. On March 11, 2020, the World Health Organization declared COVID-19 a pandemic. Further, the COVID-19 outbreak has resulted in government authorities around the world implementing numerous measures to try to reduce the spread of COVID-19, such as travel bans and restrictions, quarantines, “shelter-in-place,” “stay-at-home,” total lock-down orders, business limitations or shutdowns and similar orders. As a result, the COVID-19 pandemic has negatively impacted the global economy, disrupted global supply chains and workforce participation, and created significant volatility and disruption of financial markets. In an effort to first and foremost protect the health and safety of our employees, we also took proactive action to adopt social distancing policies at our locations globally, including working from home for certain employees, limiting the number of employees attending meetings, reducing the number of people in our locations at any one time, and suspending employee travel.

However, the disruptive impacts caused by the COVID-19 pandemic have since affected and continue to affect our operations in all other regions. For example, starting in mid-March, our Penang, Malaysia operation, which includes our largest precision machining facility, was significantly disrupted. As a result, our Penang, Malaysia operation had been operating at approximately 30% of capacity through the end of the first quarter of 2020, at approximately 50% of capacity through April of 2020 and subsequently ramped to full production capacity within a couple of weeks thereafter. Our California operations experienced significant disruptions through April 2020 due to “shelter-in-place” and “stay-at-home” orders and

ordinances. Also, our operations in Tijuana and Guadalajara, Mexico have experienced and continue to experience significant disruptions due to similar “shelter-in-place” and “stay-at-home” orders and ordinances. We resumed operations in Tijuana and Guadalajara during the middle of May of 2020 and are returning to full production in phases. We continue to operate at approximately 75% of capacity due to high risk employee regulations.

Further, we have experienced, and continue to experience, a challenging supply chain environment and labor constraints due to the COVID-19 pandemic.

As a result of the COVID-19 pandemic, our revenue for the first six months of 2020 was negatively impacted primarily as a result of operational inefficiencies relating to reduced productivity levels throughout our facilities and supply chain constraints, which affected our ability to support customer demand. Additionally, the COVID-19 pandemic negatively impacted our first and second quarter results due to increased direct costs associated with labor expenses and personal protective equipment for our employees, as well as under absorption of fixed costs.

The COVID-19 pandemic continues to affect the Company’s operations into the third quarter of 2020, due in large part to government enacted plant shut-downs, stay-at-home or shelter-in-place or similar restrictions, particularly in our operations in Guadalajara and Tijuana, Mexico, as discussed above. As a result, we expect our revenue will continue to be negatively impacted during the third quarter of 2020 and beyond as a result of continued operational inefficiencies and supply chain constraints, in addition to elevated labor expenses, resulting from the COVID-19 pandemic. We also anticipate that we may experience customer demand fluctuation, particularly due to disruptions to the businesses and operations of our customers due to the COVID-19 pandemic.

International authorities in various jurisdictions have also allowed for cash grants, delay of tax filings, and delay of tax payments for future quarters. We have taken advantage of these benefits by delaying our tax filings and respective tax payments in various jurisdictions.

In response to uncertainties related to the impact of the COVID-19 virus, we have taken a series of actions to lower our cost structure and reduce capital expenditures. On April 29, 2020, the Company announced a temporary 10% salary reduction for all executive officers (including our named executive officers) effective April 27, 2020 through December 31, 2020 and the Company Board of Directors approved a temporary 10% reduction in their quarterly cash compensation effective April 27, 2020 through December 31, 2020. Other senior leaders in the Company have taken a 7% salary reduction through September 29, 2020. Additional cost reduction actions in our U.S. factories consist of employees taking rotating time off

depending on the factory loading levels. Cost reduction actions in our non-U.S. locations depend on local law requirements. Additionally, we have reduced variable compensation and other discretionary expenses, such as travel. We have also implemented actions to conserve our cash and cash equivalents such as reducing planned capital expenditures, deferring certain planned investments, suspending our share repurchase activity, and deferring payroll and income tax payments in accordance with the CARES Act. Finally, we have implemented certain other procedures to manage potential risks related to working capital such as closely monitoring the financial stability, payment terms and credit limits of our customers.

We continue to monitor the rapidly evolving situation and guidance from international and domestic authorities, including federal, state and local public health authorities, and may take additional actions based on their recommendations. In these circumstances, there may be developments outside our control requiring us to adjust our operating plan. As such, the exact extent of the impact of the COVID-19 pandemic on our business, financial condition and results of operations, is currently unknown and will depend on future developments, which are highly uncertain, continuously evolving and cannot be predicted. This includes, but is not limited to, the duration and spread of the COVID-19 pandemic, its severity, the actions to contain the virus or treat its impact and how quickly and to what extent normal economic and operating conditions can resume.

Accordingly, our current results and financial condition discussed herein may not be indicative of future operating results and trends. See “Risk Factors” in Part II, Item 1A of this Report for additional risks we face due to the COVID-19 pandemic.

Second Quarter 2020 Highlights

Sales for the three months ended June 30, 2020 decreased 18% to $491.0 million compared to $601.6 million during the comparable 2019 period. During the second quarter of 2020, sales to customers in our various industry sectors fluctuated from the comparable 2019 period as follows:

Higher-Value Markets

· Industrials decreased by 24%,

· A&D decreased by 17%,

· Medical increased by 18%, and

· Semi-Cap increased by 39%.

Traditional Markets

· Computing decreased by 67%, and

· Telecommunications decreased by 29%.

Overall, higher-value market revenues during the second quarter were flat year-over-year. Demand strength in Medical supporting COVID-19 solutions and new product ramps and the continued Semi-Cap recovery were offset by weakness in commercial Aerospace and Industrials markets. Traditional market revenues were down 54% year-over-year primarily from our exit of the legacy Computing contract as discussed below.

Our sales depend on the success of our customers, some of which operate in businesses associated with rapid technological change and consequent product obsolescence. Developments adverse to our major customers or their products, or the failure of a major customer to pay for components or services, including in each case as a result of the COVID-19 pandemic, can adversely affect us. A substantial percentage of our sales are made to a small number of customers, and the loss of a major customer, if not replaced, would adversely affect us. Sales to our ten largest customers represented 43% and 41% of our sales in the six months ended June 30, 2020 and 2019, respectively.

During 2018, as part of our ongoing process to review contracts that are marginal and dilutive to our gross margin, we made the decision to not renew the legacy contract with a large Computing customer that was

to expire at the end of 2019. During the second quarter of 2019, we completed the final build out of this legacy contract and in the third quarter of 2019 had an immaterial amount of revenue from this contract as the transition was completed.

We experience fluctuations in gross profit from period to period. Different programs contribute different gross margins depending on the type of services involved, location of production, size of the program, complexity of the product and level of material costs associated with the various products. Moreover, new programs can contribute relatively less to our gross profit in their early stages when manufacturing volumes are usually lower, resulting in inefficiencies and unabsorbed manufacturing overhead costs. In addition, several of our new and higher-volume programs remain subject to competitive constraints that can exert downward pressure on our margins. During periods of low production volume and slow new program ramps, we generally have idle capacity and reduced gross margin. Gross profit can also be impacted by other situations, such as the current COVID-19 global pandemic discussed above and the ransomware incident experienced in 2019.

We have undertaken initiatives to restructure our business operations with the intention of improving utilization and reducing costs. During the first six months of 2020, we recognized $7.6 million of restructuring charges and other costs due in part to expenses associated with various site closures and restructuring activities, in addition to our go to market changes. In addition, during the first six months of 2020, we incurred $1.0 million in costs related to an asset impairment in Asia.

RESULTS OF OPERATIONS

The following table presents the percentage relationship that certain items in our Condensed Consolidated Statements of Income bear to sales for the periods indicated. The financial information and the discussion below should be read in conjunction with the Condensed Consolidated Financial Statements and Notes thereto in Part I, Item 1 of this Report.

		Three Months Ended				Six Months Ended
		June 30,				June 30,
			2020		2019		2020		2019

Sales			100.0	%	100.0	%	100.0	%	100.0	%
Cost of sales			92.9		91.8		92.2		91.8
	Gross profit		7.1		8.2		7.8		8.2
Selling, general and administrative expenses			5.8		5.2		6.0		5.1
Amortization of intangible assets			0.5		0.4		0.5		0.4
Restructuring charges and other costs			1.2		0.6		0.9		0.4
	Income (loss) from operations		(0.4)		2.0		0.5		2.3
Other income (expenses), net			(0.4)		0.0		(0.4)		0.1
	Income (loss) before income taxes		(0.8)		2.0		0.1		2.4
Income tax expense (benefit)			(0.1)		0.4		—		0.5
	Net income (loss)		(0.7)	%	1.6	%	—	%	1.9	%

Sales

Sales for the second quarter of 2020 were $491.0 million, a 18% decrease from sales of $601.6 million for the same quarter in 2019. Sales for the first six months of 2020 were $1.0 billion, a 16% decrease from sales of $1.2 billion for the same period in 2019. Sales by industry sector were as follows:

		Three Months Ended				Six Months Ended
		June 30,				June 30,
(in thousands)			2020		2019		2020		2019
	Higher-Value Markets
Industrials		$	87,130	$	114,664	$	189,956	$	231,037
A&D			88,524		106,965		207,724		210,854
Medical			134,751		114,187		252,727		217,665
Semi-Cap			86,851		62,450		169,571		128,471
			397,256		398,266		819,978		788,027
	Traditional Markets
Computing			43,853		132,690		80,454		257,000
Telecommunications			49,857		70,646		105,498		159,395
			93,710		203,336		185,952		416,395
	Total	$	490,966	$	601,602	$	1,005,930	$	1,204,422

Industrials. Second quarter sales decreased 24% to $87.1 million from $114.7 million in 2019. Sales during the first six months of 2020 decreased 18% to $190.0 million from $231.0 million in the same period of 2019. The decreases were primarily from softer demand from customers in the oil and gas industry and in both industrial commercial building and transportation markets, in addition to ramp delays from previously booked new programs.

Aerospace and Defense. Second quarter sales decreased 17% to $88.5 million from $107.0 million in 2019. Sales during the first six months of 2020 were $207.7 million compared to $210.8 million in the same period of 2019. The decreases were due primarily to the weakness in the commercial Aerospace market.

Medical. Second quarter sales increased 18% to $134.8 million from $114.2 million in 2019. Sales increased 16% to $252.7 million during the first six months of 2020 from $217.7 million in the same period of 2019. These increases were primarily due to new program ramps and strength throughout our medical customers and increasing demand for critical devices supporting COVID-19 solutions and new product ramps.

Semiconductor Capital Equipment. Second quarter sales increased 39% to $86.9 million from $62.4 million in 2019. Sales during the first six months of 2020 increased 32% to $169.6 million from $128.5 million in the same period of 2019. These increases were due to continued Semi-Cap market recovery.

Computing. Second quarter sales decreased 67% to $43.8 million from $132.7 million in 2019, and decreased 69% to $80.4 million during the first six months of 2020 from $257.0 million in the same period of 2019. These decreases were primarily related to our exit from a legacy contract as discussed above.

Telecommunications. Second quarter sales decreased 29% to $49.9 million from $70.6 million in 2019 and decreased 34% to $105.5 million during the first six months of 2020 from $159.4 million in the same period of 2019. The decreases were primarily due to softer demand from broadband products and commercial satellite applications.

Our international operations are subject to the risks of doing business abroad. See Part I, Item 1A of our 2019 10-K for factors pertaining to our international sales and fluctuations in the exchange rates of foreign currency and for further discussion of potential adverse effects in operating results associated with the risks

of doing business abroad. During the first six months of 2020 and 2019, 50% and 44%, respectively of our sales were from our international operations.

Gross Profit

Gross profit decreased 30% to $34.6 million for the three months ended June 30, 2020 from $49.2 million in the same quarter of 2019, and decreased 21% to $78.0 million for the six months ended June 30, 2020 from $99.3 million in the same period of 2019. For each of the three and six months ended June 30, 2020, gross profit included a $0.4 million recovery associated with customer insolvencies in 2020. For the three and six months ended June 30, 2019, gross profit included a $16 thousand and $1.0 million recovery, respectively, associated with customer insolvencies in 2019. In addition, gross profit for the three and six months ended June 30, 2019 included a $0.8 million settlement accrual with a customer. Gross margin including these charges and recoveries was 7.1% and 7.8%, respectively, for the three and six months ended June 30, 2020 and 8.2% for each of the three and six months ended June 30, 2019. Excluding these items, gross margin was 7.0% and 7.7%, respectively, for the three and six months ended June 30, 2020 compared to 8.3% and 8.2%, respectively, in the same periods of 2019. The deterioration in gross margin when comparing the periods is primarily attributable to lower revenues and the disruptive impacts caused by the COVID-19 driven by reduced productivity levels throughout our facilities, supply chain constraints, increased direct costs associated with labor expenses and personal protective equipment for our employees and under absorption of fixed costs.

Selling, General and Administrative Expenses

SG&A decreased by 9.0% to $28.5 million in the second quarter of 2020 compared to $31.5 million in 2019, and decreased by 2% to $60.1 million in the first six months of 2020 compared to $61.5 million in 2019. During the six months ended June 30, 2019, we had a $1.7 million recovery of a provision for accounts receivable associated with the insolvency of a customer. Including these adjustments to the provision to accounts receivable, SG&A increased to 5.8% of sales for the second quarter of 2020 from 5.2% in 2019, and increased to 6.0% of sales for the first six months of 2020 from 5.1% in 2019. Excluding these adjustments to the provision to accounts receivable, SG&A increased to 5.8% of sales for the second quarter of 2020 from 5.2% in 2019, and increased to 6.0% of sales for the first six months of 2020 from 5.2% in 2019, primarily due to lower sales and a $2.1 million provision for bad debts recorded in 2020.

Amortization of Intangible Assets

Amortization of intangible assets was $4.8 million in the first six months of 2020 and compared to $4.7 million in 2019.

Restructuring Charges and Other Costs

During the first six months of 2020, we recognized $7.3 million of restructuring charges, primarily related to site closures and restructuring activities in certain facilities in the Americas and Asia. In addition, during the first six months of 2020, we incurred $1.0 million in costs related to an asset impairment in Asia. In the first six months of 2019, we recognized $2.3 million of restructuring charges, primarily related to reductions in workforce in certain facilities in the Americas and Asia. In addition, during the first six months of 2019, we incurred $2.7 million in costs primarily related to fees and costs incurred in reaching the cooperation agreement with Engaged Capital and other proxy related activities as well as our CEO transition. See Note 13 to the Condensed Consolidated Financial Statements in Part I, Item 1 of this Report.

Interest Expense

Interest expense increased to $4.1 million during the first six months of 2020 from $3.3 million during the comparable 2019 period due to the outstanding amounts on the Revolving Credit facility in 2020 and increased interest rates based on our higher debt leverage ratio.

Interest Income

Interest income decreased to $0.9 million during the first six months of 2020 from $2.4 million during the comparable 2019 period due primarily to lower invested cash equivalents and the lower interest rate environment.

Income Tax Expense

Income tax expense of $0.4 million represented an effective tax rate of 45.8% for the first six months of 2020, compared with $6.2 million for the comparable 2019 period, which represented an effective tax rate of 21.2%. The increase in the effective tax rate was primarily due to the mix of profits and losses in our worldwide operations.

We have been granted certain tax incentives, including tax holidays, for our subsidiaries in Malaysia and Thailand that will expire at various dates, unless extended or otherwise renegotiated, through 2021 in Malaysia and 2028 in Thailand. See Note 9 to the Condensed Consolidated Financial Statements in Part I, Item 1 of this Report.

Net Income

We reported net income of $0.4 million, or $0.01 per diluted share, for the first six months of 2020, compared with a net income of $23.2 million, or $0.58 per diluted share, for the same period in 2019. The net decrease of $22.8 million from 2019 was primarily the result of lower gross profit as well as higher restructuring charges and other costs in 2020.

LIQUIDITY AND CAPITAL RESOURCES

We have historically financed our organic growth and operations through funds generated from operations and occasional borrowings under our revolving credit facility. Cash and cash equivalents and restricted cash totaled $356.4 million at June 30, 2020 and $364.0 million at December 31, 2019, of which $162.2 million and $197.8 million, respectively, were held outside the U.S. in various foreign subsidiaries.

Cash provided by operating activities during the first six months of 2020 was $19.9 million and consisted primarily of $0.4 million of net income adjusted for $24.5 million of depreciation and amortization, a $20.4 million decrease in accounts receivable, a $7.4 million decrease in contract assets, a $7.0 million increase in accounts payable and a $3.1 million increase in accrued liabilities, partially offset by a $48.7 million increase in inventories. The decrease in accounts receivable was attributable to lower sales. The decrease in contract assets was impacted by the timing of work completed at period end. The increase in inventories is primarily related to mix changes from customers late in the first six months of 2020 and inventory to support long productions cycles for products in our Semi-Cap and Medical sectors. The increase in accounts payable was primarily a result of the timing of inventory purchases and the timing of payments. The increase in accrued liabilities was primarily a result of the timing of payments. Working capital was $0.7 billion at June 30, 2020 and at December 31, 2019.

We purchase components only after customer orders or forecasts are received, which mitigates, but does not eliminate, the risk of loss on inventories. Supplies of electronic components and other materials used in operations are subject to industry-wide shortages. In certain instances, suppliers may allocate available quantities to us. If shortages of these components and other material supplies used in operations occur, vendors may not ship the quantities we need for production, and we may be forced to delay shipments, which can increase backorders and impact cash flows. We have also experienced, and continue to experience, a challenging supply chain environment, and labor constraints due to the COVID-19 virus.

Cash used in investing activities during the first six months was $20.7 million for 2020, primarily due to

purchases of additional property, plant and equipment totaling $21.4 million. The purchases of property, plant and equipment were primarily for machinery and equipment in the Americas and Asia.

Cash used in financing activities during the first six months of 2020 was $6.5 million. Share repurchases totaled $19.3 million, net borrowing activities on long-term debt totaled $25.6 million, dividends totaled $11.4 million, and we received $0.4 million from the exercise of stock options.

Under the terms of our $650.0 million Credit Agreement, in addition to the Term Loan facility, we have a $500.0 million five-year revolving credit facility to be used for general corporate purposes (subject to compliance with financial covenants as to interest coverage and debt leverage, in addition to other debt covenant restrictions), both with a maturity date of July 20, 2023. The Credit Agreement includes an accordion feature pursuant to which total commitments under the facility may be increased by an additional $275.0 million, subject to satisfaction of certain conditions. As of June 30, 2020, we had $140.6 million in borrowings outstanding under the Term Loan Facility and $30.0 million in borrowings and $3.7 million in letters of credit outstanding under the Revolving Credit Facility, respectively. See Note 6 to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this Report for more information regarding the terms of the Credit Agreement.

The Credit Agreement contains certain financial covenants as to interest coverage and debt leverage, and certain customary affirmative and negative covenants, including restrictions on our ability to incur additional debt and liens, pay dividends, repurchase shares, sell assets and merge or consolidate with other persons. Amounts due under the Credit Agreement could be accelerated upon specified events of default, including a failure to pay amounts due, breach of a covenant, material inaccuracy of a representation, or occurrence of bankruptcy or insolvency, subject, in some cases, to cure periods. As of June 30, 2020, we were in compliance with all these covenants and restrictions.

Our operations, and the operations of businesses we acquire, are subject to certain foreign, federal, state and local regulatory requirements relating to environmental, waste management, health and safety matters. We believe we operate in substantial compliance with all applicable requirements and we seek to ensure that newly acquired businesses comply or will comply substantially with applicable requirements. To date, the costs of compliance and workplace and environmental remediation have not been material to us. However, material costs and liabilities may arise from these requirements or from new, modified or more stringent requirements in the future. In addition, our past, current and future operations, and the operations of businesses we have or may acquire, may give rise to claims of exposure by employees or the public, or to other claims or liabilities relating to environmental, waste management or health and safety concerns.

As of June 30, 2020, we had cash and cash equivalents and restricted cash totaling $356.4 million and $466.3 million available for borrowings under the Revolving Credit Facility, subject to compliance with financial covenants as to interest coverage and debt leverage, in addition to other debt covenant restrictions as described above. During the next 12 months, we believe our capital expenditures will approximate $30 million to $35 million, principally for machinery and equipment to support our ongoing business around the globe, in addition to expenditures for information technology infrastructure items and software.

On October 26, 2018, our Board of Directors approved an expanded stock repurchase program granting us the authority to repurchase up to $100 million in common stock in addition to the $250 million approved on March 6, 2018. On February 19, 2020, the Board of Directors authorized the repurchase of an additional $150 million of the Company’s common stock. As of June 30, 2020, we had $210.1 million remaining under the share repurchase authorization to purchase additional shares. We are under no commitment or obligation to repurchase any amount of common stock.

Management believes that our existing cash balances and funds generated from operations will be enough to permit us to meet our liquidity requirements over the next 12 months. Management further believes that our ongoing cash flows from operations and any borrowings we may incur under our Revolving Credit Facility will enable us to meet operating cash requirements in future years. If we consummated significant acquisitions in the future, our capital needs would increase and could possibly result in our need to increase available borrowings under our Credit Agreement or access public or private debt and equity markets. There can be no assurance, however, that we would be successful in raising additional debt or equity on acceptable terms.

CONTRACTUAL OBLIGATIONS

We have certain contractual obligations for operating and capital leases that were summarized in a table of Contractual Obligations in our 2019 10-K. There have been no material changes to our contractual obligations, outside of the ordinary course of our business, since December 31, 2019.

OFF-BALANCE SHEET ARRANGEMENTS

As of June 30, 2020, we did not have any significant off-balance sheet arrangements. See Note 16 to the Condensed Consolidated Financial Statements.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES AND RECENTLY ENACTED ACCOUNTING PRINCIPLES

Management’s discussion and analysis is based upon our Condensed Consolidated Financial Statements, which have been prepared in accordance with U.S. GAAP. See Note 2 to the Condensed Consolidated Financial Statements in Part 1, Item 1 of this Report for a discussion of recently enacted accounting principles. Also, our significant accounting policies are summarized in Note 1 to the Consolidated Financial Statements included in our 2019 10-K.

Item 3 – Quantitative and Qualitative Disclosures About Market Risk

Our international sales comprise a significant portion of our net sales. We are exposed to risks associated with operating internationally, including:

•Foreign currency exchange risk;

•Import and export duties, taxes and regulatory changes;

•Inflationary economies or currencies; and

•Economic and political instability.

Additionally, some of our operations are in developing countries. Certain events, including natural disasters, can impact the infrastructure of a developing country more severely than they would impact the infrastructure of a developed country. A developing country can also take longer to recover from such events, which could lead to delays in our ability to resume full operations.

We transact business in various foreign countries and are subject to foreign currency fluctuation risks. We use natural hedging and forward contracts to economically hedge transactional exposure primarily associated with trade accounts receivable, other receivables and trade accounts payable that are denominated in a currency other than the functional currency of the respective operating entity. We do not use derivative financial instruments for speculative purposes. The forward contract in place as of June 30, 2020 has not been designated as an accounting hedge and, therefore, changes in fair value are recorded within our Condensed Consolidated Statements of Income.

Our sales are substantially denominated in U.S. dollars. Our foreign currency cash flows are generated in certain European and Asian countries and Mexico.

We are also exposed to market risk for changes in interest rates on our financial instruments, a portion of which relates to our invested cash balances. We do not use derivative financial instruments in our investing activities. We place cash and cash equivalents and investments with various major financial institutions. We protect our invested principal funds by limiting default risk, market risk and reinvestment risk. We mitigate default risk by generally investing in investment-grade securities.

We are also exposed to interest rate risk on borrowings under our Credit Agreement. As of June 30, 2020, we had $30.0 million outstanding on the floating rate revolving credit facility. In addition, we had $140.6 million outstanding on the floating rate term loan facility, and we have an interest rate swap agreement with a notional amount of $140.6 million. Under this swap agreement, we receive variable rate interest rate payments and pay fixed rate interest payments. The effect of this swap is to convert a portion our floating rate interest expense to fixed interest rate expense. The interest rate swap is designated as a cash flow hedge. For additional information, see Note 16 to the Condensed Consolidated Financial Statements in Item 1 of this Report.

Item 4 – Controls and Procedures

As of the end of the period covered by this Report, the Company’s management (with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO)) conducted an evaluation pursuant to Rule 13a-15 under the Exchange Act, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act). Based on this evaluation, the CEO and CFO concluded that as of the end of the period covered by this Report such disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by the Company in reports it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to our management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

There has been no change in our internal control over financial reporting (as defined in Rule13a-15(f) or 15d-15(f) of the Exchange Act) that occurred during the last fiscal quarter covered by this Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by individuals’ acts, by collusion of two or more people, or by management overriding the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

We are involved in various legal actions arising in the ordinary course of business. There have been no material changes to the legal proceedings previously reported under Part I, Item 3 of our 2019 10-K, and, in the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial position or results of operations.

Item 1A.Risk Factors

Except as set forth below, there have been no material changes to the risk factors previously disclosed in Part I, Item 1A of our 2019 10-K.

Our business, financial condition and results of operations have been and are expected to continue to be adversely affected by the recent novel coronavirus (COVID-19) pandemic, the extent of which is uncertain and difficult to predict.

Benchmark provides critical infrastructure products and essential services in each of our locations. However, as a result of the COVID-19 pandemic, including the related responses from government authorities, the Company’s operations were impacted worldwide starting in the first quarter of 2020. For example, several of the Company’s facilities worldwide have been, or continue to be, affected by government enacted plant shut-downs, stay-at-home or shelter-in-place or similar restrictions, which have resulted in reduced productivity levels throughout our facilities. Additionally, the Company experienced, and continues to experience, a challenging supply chain environment and labor constraints, as well as increased direct costs and under absorption of fixed costs, due to the COVID-19 pandemic. For additional information see “—COVID-19 Pandemic Update” in Part I, Item 2 of this Report.

Additionally, our business, financial condition and results of operations have been and may be further impacted in several ways, including, but not limited to, the following:

· further disruptions to our operations, including due to additional facility closures, restrictions on our operations and sales, marketing and distribution efforts and/or interruptions to our engineering and design processes and other important business activities;

· reduced demand for our products and services, particularly due to disruptions to the businesses and operations of our customers;

· interruptions, availability or delays in global shipping to transport our products;

· further slowdown or stoppage in the supply chain for our products, in addition to higher costs;

· limitations on employee resources and availability, including due to sickness, government restrictions, the desire of employees to avoid contact with large groups of people or mass transit disruptions;

· greater difficulty in collecting customer receivables;

· a fluctuation in foreign currency exchange rates or interest rates could result from market uncertainties;

· an increase in the cost or the difficulty to obtain debt or equity financing could affect our financial condition or our ability to fund operations or future investment opportunities;

· any breach of financial covenants contained in the Credit Agreement;

· current or near future trends may cause certain inventory to be slow-moving and trigger the need to review for excess and obsolete inventory or the valuation of inventory;

· changes to the carrying value of our goodwill and intangible assets; and

· an increase in regulatory restrictions or continued market volatility could hinder our ability to execute strategic business activities, as well as negatively impact our stock price.

The spread of COVID-19 has caused us to modify our business practices (including employee travel, employee work locations, and cancellation of physical participation in meetings, events and conferences), and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers, partners, and suppliers. There is no certainty that such measures will be enough to mitigate the risks posed by the virus, and our ability to perform critical functions could be harmed.

Additionally, COVID-19 could impact our internal controls over financial reporting as a portion of our workforce is required to work from home and therefore new processes, procedures, and controls could be required to respond to changes in our business environment. Further, should any key employees become ill from COVID-19 and unable to work, the attention of the management team could be diverted.

Any of the foregoing could adversely affect our business, financial condition and results of operations. The potential effects of COVID-19 may also impact many of our other risk factors discussed in “Risk Factors” in Part I, Item 1A in our 2019 10-K. The exact extent of the impact of the COVID-19 pandemic on our business, financial condition and results of operations will depend on future developments, which are highly uncertain, continuously evolving and cannot be predicted, including, but not limited to, the duration and spread of the COVID-19 outbreak, its severity, the actions to contain the virus or treat its impact and how quickly and to what extent normal economic and operating conditions can resume.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

(c) The following table provides information for the quarter ended June 30, 2020 about the Company’s repurchases of its equity securities registered pursuant to Section 12 of the Exchange Act:

ISSUER PURCHASES OF EQUITY SECURITIES
					(d) Maximum
				(c) Total	Number (or
				Number of	Approximate
				Shares	Dollar Value)
				(or Units)	of Shares
				Purchased as	(or Units) that
	(a) Total			Part of	May Yet Be
	Number of			Publicly	Purchased
	Shares (or		(b) Average	Announced	Under the
	Units)	Price Paid per Share		Plans or	Plans or
Period	Purchased⁽¹⁾		(or Unit)⁽²⁾	Programs	Programs⁽³⁾
April 1 to 30, 2020	—		—	—	$210.1 million
May 1 to 31, 2020	—		—	—	$210.1 million
June 1 to 30, 2020	—		—	—	$210.1 million
Total	—		—	—

⁽¹⁾ All stock repurchases were made on the open market.

⁽²⁾Average price paid per share is calculated on a settlement basis and excludes commission.

⁽³⁾On October 30, 2018, the Company announced that the Board of Directors authorized the repurchase of $100 million of the Company’s common stock in addition to the $250 million previously announced on March 7, 2018. On February 24, 2020, the Company announced that the Board of Directors authorized the repurchase of an additional $150 million of the Company’s common stock. Net of shares repurchased to date, the total remaining authorization outstanding as of June 30, 2020 is $210.1 million. Stock purchases may be made in the open market, in privately negotiated transactions or block transactions, at the discretion of the Company’s management and as market conditions warrant. Purchases are funded from available cash and may be commenced, suspended or discontinued at any time without prior notice. Shares of stock repurchased under the program are retired.

Item 6.Exhibits

Exhibit
Number		Description of Exhibit

3.1Restated Certificate of Formation dated May 17, 2016 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K dated May 17, 2016) (the 8-K) (Commission file number 1-10560)

3.2Amended and Restated Bylaws of the Company dated May 11, 2016 (incorporated by reference to Exhibit 3.2 to the 8-K)

4.1Specimen form of certificate evidencing the Common Shares (incorporated by reference to Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014) (Commission file number 1-10560)

31.1 ⁽¹⁾Section 302 Certification of Chief Executive Officer

31.2 ⁽¹⁾Section 302 Certification of Chief Financial Officer

32.1 ⁽²⁾Section 1350 Certification of Chief Executive Officer

32.2 ⁽²⁾Section 1350 Certification of Chief Financial Officer

101.INS ⁽¹⁾XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH ⁽¹⁾Inline XBRL Taxonomy Extension Schema Document

101.CAL ⁽¹⁾Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF ⁽¹⁾Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB ⁽¹⁾Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE ⁽¹⁾Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 ⁽¹⁾Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

⁽¹⁾ Filed herewith.

⁽²⁾ Furnished herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on August 5, 2020.

	BENCHMARK ELECTRONICS, INC.
	(Registrant)
	By: /s/ *Jeffrey W. Benck*
	Jeffrey W. Benck
	President and Chief Executive Officer
	(Principal Executive Officer)


	By: /s/ *Roop K. Lakkaraju*
	Roop K. Lakkaraju
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

This ‘10-Q’ Filing	Date	Other Filings

	7/20/23
	12/31/20	10-K, SD
	9/29/20
Filed as of:	8/6/20
Filed on:	8/5/20
	8/4/20
	7/14/20
For Period end:	6/30/20
	6/15/20	8-K
	4/29/20	8-K
	4/27/20
	3/31/20	10-Q
	3/27/20
	3/11/20
	2/24/20	4, 8-K
	2/19/20	8-K
	1/1/20
	12/31/19	10-K, SD
	12/15/19
	6/30/19	10-Q
	3/31/19	10-Q
	12/31/18	10-K, 4, SD
	10/30/18	8-K
	10/26/18	8-K
	7/20/18	8-K
	3/7/18	4, 8-K
	3/6/18
	12/31/17	10-K, 5, SD
		List all Filings

Benchmark Electronics Inc. – ‘10-Q’ for 6/30/20

On: Wednesday, 8/5/20, at 5:54pm ET · As of: 8/6/20 · For: 6/30/20 · Accession #: 863436-20-24 · File #: 1-10560

Previous ‘10-Q’: ‘10-Q’ on 5/8/20 for 3/31/20 · Next: ‘10-Q’ on 11/5/20 for 9/30/20 · Latest: ‘10-Q’ on 11/2/23 for 9/30/23 · 2 References:

Quarterly Report — Form 10-Q
Filing Table of Contents

‘10-Q’ — Quarterly Report
Document Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

2 Previous Filings that this Filing References

		Page

PART I—FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Income (Loss)	2
	Condensed Consolidated Statements of Comprehensive Income (Loss)	3
	Condensed Consolidated Statements of Shareholders’ Equity	4
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and	24
	Results of Operations
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	34
Item 4.	Controls and Procedures	35

PART II—OTHER INFORMATION

Item 1.	Legal Proceedings	36
Item 1A.	Risk Factors	36
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	38
Item 6.	Exhibits	39

SIGNATURES		40

Benchmark Electronics Inc. – ‘10-Q’ for 6/30/20

On: Wednesday, 8/5/20, at 5:54pm ET · As of: 8/6/20 · For: 6/30/20 · Accession #: 863436-20-24 · File #: 1-10560

Previous ‘10-Q’: ‘10-Q’ on 5/8/20 for 3/31/20 · Next: ‘10-Q’ on 11/5/20 for 9/30/20 · Latest: ‘10-Q’ on 11/2/23 for 9/30/23 · 2 References: To: Benchmark Electronics Inc. – ‘8-K’ on 5/17/16 for 5/11/16 To: Benchmark Electronics Inc. – ‘10-Q’ on 11/7/14 for 9/30/14

Quarterly Report — Form 10-QFiling Table of Contents

‘10-Q’ — Quarterly ReportDocument Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

2 Previous Filings that this Filing References

Previous ‘10-Q’: ‘10-Q’ on 5/8/20 for 3/31/20 · Next: ‘10-Q’ on 11/5/20 for 9/30/20 · Latest: ‘10-Q’ on 11/2/23 for 9/30/23 · 2 References:

Quarterly Report — Form 10-Q
Filing Table of Contents

‘10-Q’ — Quarterly Report
Document Table of Contents